Main Page Side Effects Insurance Coverage Review Board

Does Mounjaro Cause Constipation? A Doctor Explains

Constipation is one of the most frequently reported side effects of Mounjaro (tirzepatide), a dual-action GLP-1 and GIP receptor agonist used to manage type 2 diabetes and support weight loss. While Mounjaro offers significant benefits for blood sugar control and weight reduction, its impact on gastrointestinal motility often leads to discomfort. Understanding why Mounjaro causes constipation—and how to manage it—can help patients stay on track with their treatment while minimizing disruption to daily life.


Why Does Mounjaro Cause Constipation?

Mounjaro (tirzepatide) slows gastric emptying and intestinal motility as part of its mechanism of action. As a GLP-1 receptor agonist, Mounjaro enhances insulin secretion, suppresses glucagon, and promotes satiety—effects that are beneficial for diabetes and weight management. However, GLP-1 also delays the movement of food through the digestive tract, which can lead to harder, drier stools and reduced bowel movement frequency.

Additionally, Mounjaro’s effect on fluid absorption in the intestines may contribute to constipation. When stool moves more slowly, the colon absorbs more water, making stools firmer and more difficult to pass. Studies from clinical trials show that gastrointestinal side effects, including constipation, are dose-dependent and more pronounced during dose escalation. While not everyone experiences constipation on Mounjaro, the medication’s impact on gut motility is a well-documented contributor.


How Common Is Constipation on Mounjaro?

Constipation is a common side effect of Mounjaro, affecting a significant portion of users. In the SURPASS clinical trial program, which evaluated Mounjaro for type 2 diabetes, constipation was reported in approximately 11% to 17% of participants, depending on the dosage. Higher doses of Mounjaro (10 mg and 15 mg) were associated with a greater incidence of constipation compared to lower doses (2.5 mg and 5 mg).

For weight management, the SURMOUNT trials showed similar trends, with constipation occurring in about 16% to 20% of participants taking Mounjaro. While these rates are notable, they are generally lower than those for other gastrointestinal side effects like nausea or diarrhea. Most cases of Mounjaro-induced constipation are mild to moderate and tend to improve over time as the body adjusts to the medication.


How Long Does Mounjaro Constipation Last?

The duration of constipation while taking Mounjaro varies among individuals, but most patients experience relief within a few weeks to a few months. During the initial dose-escalation phase, when Mounjaro is gradually increased to the target dose, constipation is most likely to occur. This phase typically lasts 4 to 8 weeks, and many patients report that their symptoms improve as their digestive system adapts to the medication.

In clinical trials, constipation often peaked during the first 8 to 12 weeks of treatment and then declined in frequency and severity. However, some patients may continue to experience occasional constipation throughout their treatment with Mounjaro. If constipation persists beyond 3 months or becomes severe, it may indicate the need for dietary adjustments, hydration strategies, or medical intervention.


How to Manage Constipation While Taking Mounjaro

Managing constipation while on Mounjaro involves a combination of dietary modifications, hydration, physical activity, and, in some cases, over-the-counter remedies. Increasing fiber intake is one of the most effective strategies. Soluble fiber, found in foods like oats, apples, and beans, softens stools and promotes regularity. Insoluble fiber, such as whole grains and vegetables, adds bulk to stools and stimulates bowel movements. Aim for 25 to 35 grams of fiber per day, but increase intake gradually to avoid bloating.

Hydration is equally important, as fiber works best when paired with adequate water intake. Drinking at least 8 cups of water daily can help prevent stools from becoming too hard. Regular physical activity, such as walking or light exercise, also stimulates intestinal motility and can alleviate constipation.

For persistent symptoms, over-the-counter options like polyethylene glycol (Miralax) or stool softeners (docusate sodium) may provide relief. Probiotics, particularly strains like Bifidobacterium lactis, have also shown promise in improving gut motility. However, patients should consult their healthcare provider before starting any new supplement or medication, especially if they have underlying health conditions.


When to See Your Doctor About Mounjaro and Constipation

While constipation is a common and often manageable side effect of Mounjaro, there are instances when medical attention is necessary. Patients should consult their doctor if constipation persists for more than 3 weeks despite lifestyle and dietary changes, or if it is accompanied by severe symptoms such as abdominal pain, bloating, vomiting, or the inability to pass gas. These could indicate a more serious condition, such as a bowel obstruction, which requires immediate evaluation.

Additionally, if constipation leads to complications like hemorrhoids, anal fissures, or rectal bleeding, medical intervention may be needed. Patients with a history of gastrointestinal disorders, such as irritable bowel syndrome (IBS) or diverticulitis, should also discuss their symptoms with their provider, as Mounjaro may exacerbate these conditions. In some cases, adjusting the Mounjaro dosage or switching to an alternative medication may be necessary to balance efficacy and tolerability.


Mounjaro Constipation vs Other GLP-1 Side Effects

Constipation is just one of several gastrointestinal side effects associated with Mounjaro and other GLP-1 receptor agonists. Compared to nausea and diarrhea, which are more commonly reported, constipation tends to be less severe but can be more persistent. Nausea, for example, often occurs early in treatment and resolves within a few weeks, while constipation may linger or recur intermittently.

Other GLP-1 medications, such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda), also list constipation as a side effect, but the incidence varies. Mounjaro, which targets both GLP-1 and GIP receptors, may have a slightly different side effect profile. Some patients report that Mounjaro causes less nausea but more constipation compared to other GLP-1 agonists. Understanding these differences can help patients and providers tailor treatment plans to minimize discomfort.


Does Mounjaro Dosage Affect Constipation?

The dosage of Mounjaro plays a significant role in the likelihood and severity of constipation. Clinical trials have shown that higher doses of Mounjaro (10 mg and 15 mg) are associated with a greater incidence of constipation compared to lower doses (2.5 mg and 5 mg). This dose-dependent relationship is consistent with Mounjaro’s mechanism of action, as higher doses more strongly inhibit gastric emptying and intestinal motility.

Patients starting Mounjaro typically begin with a low dose (2.5 mg) and gradually titrate upward over several weeks. This slow escalation helps the body adapt to the medication and may reduce the severity of side effects, including constipation. If constipation becomes problematic at higher doses, patients may discuss with their provider the possibility of slowing the titration schedule or temporarily reducing the dose until symptoms improve.


Frequently Asked Questions

Does Mounjaro cause constipation in everyone?

No, Mounjaro does not cause constipation in everyone. While it is a common side effect, affecting about 11% to 20% of users, many patients tolerate the medication without significant gastrointestinal issues. Individual responses to Mounjaro vary based on factors like dosage, diet, hydration, and underlying gut health.

How long does constipation last on Mounjaro?

Constipation on Mounjaro often peaks during the first 8 to 12 weeks of treatment, particularly during dose escalation. For most patients, symptoms improve within a few weeks to months as the body adjusts. However, some individuals may experience occasional constipation throughout their treatment.

Can you prevent constipation on Mounjaro?

While constipation cannot always be prevented, proactive measures can reduce its likelihood and severity. Increasing fiber and water intake, staying physically active, and following a gradual dose-escalation schedule can help. Over-the-counter remedies like stool softeners or probiotics may also be beneficial for some patients.

Is constipation a reason to stop Mounjaro?

Constipation alone is rarely a reason to discontinue Mounjaro, especially if it is mild and manageable. However, if constipation is severe, persistent, or accompanied by complications like pain or bleeding, patients should consult their doctor. Alternative treatments or dosage adjustments may be considered to improve tolerability.


Disclaimer from HealthLeague Medical Board: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your medication or treatment plan. Individual responses to Mounjaro (tirzepatide) may vary, and side effects should be discussed with a qualified medical professional.

References

  1. FDA Prescribing Information for GLP-1 receptor agonists. U.S. Food and Drug Administration. 2024.
  2. SURPASS and SURMOUNT clinical trial programs. Eli Lilly and Company. 2022-2025.
  3. SUSTAIN and STEP clinical trial programs. Novo Nordisk. 2017-2024.
  4. American Diabetes Association Standards of Care in Diabetes. 2025.
  5. American Society of Health-System Pharmacists (ASHP) Drug Information. 2025.